Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy ; volume:13 ; number:1 ; day:10 ; month:10 ; year:2023 ; pages:1-7 ; date:12.2023
Scientific reports ; 13, Heft 1 (10.10.2023), 1-7, 12.2023
- Creator
-
Chubachi-Kamimura, Aya
Miki, Akiko
Hayashida-Hirano, Mayuka
Kishimoto-Kishi, Maya
Okuda, Mina
Matsumiya, Wataru
Imai, Hisanori
Kusuhara, Sentaro
Nakamura, Makoto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44415-w
- URN
-
urn:nbn:de:101:1-2024020613322980703312
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chubachi-Kamimura, Aya
- Miki, Akiko
- Hayashida-Hirano, Mayuka
- Kishimoto-Kishi, Maya
- Okuda, Mina
- Matsumiya, Wataru
- Imai, Hisanori
- Kusuhara, Sentaro
- Nakamura, Makoto
- SpringerLink (Online service)
Other Objects (12)
Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy
Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy
Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy
Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy